Institut J Paoli I Calmettes; Onco Hematologie 2

Marseille 13273

0 studies enrolling now · 2 studies all time

What they study most

Leukemia, Myeloid, Acute, Myelogenous Leukemia, Acute

Studies at this site

• A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) — Stopped early
• A Study of RO5503781 as a Single Agent or in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia — Completed